Page last updated: 2024-10-29

indomethacin and Lymphangiectasis

indomethacin has been researched along with Lymphangiectasis in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Lymphangiectasis: A transient dilatation of the lymphatic vessels.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Marini, D1
Xu, J1
Sun, L1
Jaeggi, E1
Seed, M1

Reviews

1 review available for indomethacin and Lymphangiectasis

ArticleYear
Current and future role of fetal cardiovascular MRI in the setting of fetal cardiac interventions.
    Prenatal diagnosis, 2020, Volume: 40, Issue:1

    Topics: Anemia; Anti-Inflammatory Agents, Non-Steroidal; Atrial Septum; Blood Transfusion, Intrauterine; Duc

2020